Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1ywr | LI9 | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.596 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.577 | |
| 4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.577 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.572 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.559 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.559 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.557 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.553 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.551 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.548 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.540 | |
| 1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.539 | |
| 4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.539 | |
| 3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.538 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.537 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.535 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.534 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.534 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.533 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.533 | |
| 1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.532 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.532 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.531 | |
| 1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.530 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.527 | |
| 3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.527 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.527 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.527 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.526 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.525 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.524 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.521 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.521 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.521 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.521 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.520 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.520 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.519 | |
| 3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.519 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 1oz1 | FPH | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.514 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.513 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.513 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.512 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.512 | |
| 3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.511 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.511 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.510 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.510 | |
| 1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.507 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.507 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.507 | |
| 1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.506 | |
| 4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.506 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.505 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.505 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.504 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.504 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.504 | |
| 5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.504 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.502 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.501 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.500 | |
| 3obg | SB2 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.500 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.499 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.498 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.495 | |
| 3fkn | FKN | Mitogen-activated protein kinase 14 | / | 0.495 | |
| 3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.495 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.495 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.495 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.494 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.494 | |
| 2buj | STU | Serine/threonine-protein kinase 16 | / | 0.493 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.493 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.492 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.491 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.491 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.491 | |
| 1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.490 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.490 | |
| 3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.488 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.488 | |
| 3q5i | ANP | Protein kinase, putative | / | 0.487 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.487 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.486 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.486 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.486 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.486 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.486 | |
| 3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.485 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.485 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.484 | |
| 3fmm | XI2 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.484 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.482 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.482 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.481 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.480 | |
| 3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.480 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.480 | |
| 2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.479 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.478 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.478 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.478 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
| 3c50 | ADP | Rhodopsin kinase | / | 0.477 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
| 4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.477 | |
| 1bl7 | SB4 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.476 | |
| 3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.476 | |
| 3zrk | ZRK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.476 | |
| 1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.475 | |
| 2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.475 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 3dey | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.475 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.475 | |
| 3klm | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.475 | |
| 3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.475 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
| 3fml | FML | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.474 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.474 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.474 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.473 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.473 | |
| 4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.473 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.473 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
| 2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.472 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.472 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.472 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.471 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.471 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.471 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.471 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
| 2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.470 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.470 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.470 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
| 4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
| 1yqj | 6NP | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.469 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.469 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.469 | |
| 2qa2 | FAD | Polyketide oxygenase CabE | / | 0.469 | |
| 3orm | AGS | Serine/threonine protein kinase | / | 0.469 | |
| 4bqp | VMY | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.469 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
| 3iae | D7K | Benzaldehyde lyase | / | 0.468 | |
| 3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
| 3zsg | T75 | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.468 | |
| 4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
| 1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
| 3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.467 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.467 | |
| 4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
| 2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.466 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.465 | |
| 2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.465 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 3huc | G97 | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.464 | |
| 1nzd | UPG | DNA beta-glucosyltransferase | / | 0.464 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.464 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.464 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.464 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.463 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
| 2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.463 | |
| 2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.463 | |
| 3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
| 4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
| 4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.463 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.463 | |
| 4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.463 | |
| 5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
| 4enh | FVX | Cholesterol 24-hydroxylase | / | 0.462 | |
| 4gxs | 0YS | Glutamate receptor 2 | / | 0.462 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.462 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.461 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.461 | |
| 3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.461 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
| 1ie4 | T44 | Transthyretin | / | 0.460 | |
| 1kgj | FL8 | Transthyretin | / | 0.460 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
| 1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
| 2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.460 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.460 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
| 4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
| 4l43 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.460 | |
| 2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.459 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.459 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.459 | |
| 3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
| 4a0m | NAD | Betaine aldehyde dehydrogenase, chloroplastic | 1.2.1.8 | 0.459 | |
| 4cy8 | FDA | 2-hydroxybiphenyl-3-monooxygenase | / | 0.459 | |
| 4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.459 | |
| 4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.459 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 2c3i | IYZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
| 3iw5 | DF3 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.458 | |
| 3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
| 4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.458 | |
| 1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.457 | |
| 1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
| 1s6q | TPB | Gag-Pol polyprotein | 2.7.7.49 | 0.457 | |
| 1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.457 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.457 | |
| 2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.457 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 3blq | ATP | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.457 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.457 | |
| 3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.457 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.457 | |
| 3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
| 3uwq | U5P | Orotidine 5'-phosphate decarboxylase | / | 0.457 | |
| 4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.457 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.457 | |
| 4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.457 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.456 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
| 2pv7 | NAD | T-protein | 1.3.1.12 | 0.456 | |
| 3d8v | UD1 | Bifunctional protein GlmU | / | 0.456 | |
| 3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
| 4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
| 4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.456 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.456 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.456 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
| 1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
| 2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.455 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
| 4j1r | I5R | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.454 | |
| 2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.454 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.454 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
| 4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.453 | |
| 2hw1 | ANP | Ketohexokinase | / | 0.453 | |
| 2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.453 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
| 3kkv | B99 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 3mia | ANP | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.453 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.453 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.453 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.453 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.452 | |
| 2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.452 | |
| 2q4w | FAD | Cytokinin dehydrogenase 7 | 1.5.99.12 | 0.452 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.452 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.452 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.452 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
| 3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
| 3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.452 | |
| 3h9f | 92M | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
| 3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.452 | |
| 4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
| 4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
| 1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.451 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 1yin | CM3 | Estrogen receptor | / | 0.451 | |
| 1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.451 | |
| 2fzh | DH1 | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
| 2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
| 3swr | SFG | DNA (cytosine-5)-methyltransferase 1 | 2.1.1.37 | 0.451 | |
| 3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.451 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.451 | |
| 4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.451 | |
| 5auz | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.451 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.450 | |
| 1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 1uy7 | PU4 | Heat shock protein HSP 90-alpha | / | 0.450 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 2bil | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
| 2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.450 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.450 | |
| 3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.450 | |
| 3r02 | UNM | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
| 3zok | NAD | 3-dehydroquinate synthase, chloroplastic | 4.2.3.4 | 0.450 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
| 4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
| 4eh3 | NAR | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
| 4s34 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
| 1dkf | BMS | Retinoic acid receptor alpha | / | 0.449 | |
| 1g67 | TZP | Thiamine-phosphate synthase | / | 0.449 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 2c6h | PXI | Cytochrome P450 monooxygenase PikC | / | 0.449 | |
| 2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.449 | |
| 2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.449 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.449 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.449 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.449 | |
| 3q9y | TXQ | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.449 | |
| 4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.449 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.449 | |
| 5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
| 5jqb | IBP | Envelope glycoprotein | / | 0.449 | |
| 1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.448 | |
| 1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
| 2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.448 | |
| 3eek | 53S | Uncharacterized protein | / | 0.448 | |
| 3fi3 | JK2 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
| 3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.448 | |
| 4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.448 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.448 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.447 | |
| 1v0o | INR | Cell division control protein 2 homolog | 2.7.11.22 | 0.447 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.447 | |
| 2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.447 | |
| 3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.447 | |
| 4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.447 | |
| 4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.447 | |
| 5dc5 | B3N | Histone deacetylase 8 | 3.5.1.98 | 0.447 | |
| 1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 2g44 | T3O | Estrogen receptor | / | 0.446 | |
| 2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.446 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.446 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 3au8 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic | 1.1.1.267 | 0.446 | |
| 3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.446 | |
| 3ori | AGS | Serine/threonine protein kinase | / | 0.446 | |
| 3ump | ATP | ATP-dependent 6-phosphofructokinase isozyme 2 | 2.7.1.11 | 0.446 | |
| 4an9 | 2P7 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.446 | |
| 4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.446 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.446 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.446 | |
| 4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.446 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.446 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.446 | |
| 4xcv | NDP | Probable hydroxyacid dehydrogenase protein | / | 0.446 | |
| 5dqr | FAD | 7-hydroxymethyl chlorophyll a reductase, chloroplastic | 1.17.7.2 | 0.446 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.445 | |
| 1uom | PTI | Estrogen receptor | / | 0.445 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
| 2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.445 | |
| 2w3v | TOP | Dihydrofolate reductase | / | 0.445 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.445 | |
| 3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
| 3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.445 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.445 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.445 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.445 | |
| 4nt0 | 3DU | Orotidine 5'-phosphate decarboxylase | 4.1.1.23 | 0.445 | |
| 4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.445 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.444 | |
| 1j3k | WRA | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.444 | |
| 1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 2i4z | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 2w4i | VGA | Glutamate racemase | / | 0.444 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.444 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
| 3anl | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.444 | |
| 3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.444 | |
| 3flq | 891 | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3nbw | TR4 | Ketohexokinase | / | 0.444 | |
| 3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.444 | |
| 4a4x | JUP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.444 | |
| 4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.444 | |
| 4b8z | NAP | GDP-L-fucose synthase | 1.1.1.271 | 0.444 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.444 | |
| 4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
| 4icy | FAD | PgaE | / | 0.444 | |
| 4l4b | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.443 | |
| 1j39 | UPG | DNA beta-glucosyltransferase | / | 0.443 | |
| 1sn5 | T3 | Transthyretin | / | 0.443 | |
| 1v9a | SAH | Uncharacterized protein | / | 0.443 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 2woe | AR6 | ADP-ribosyl-[dinitrogen reductase] glycohydrolase | 3.2.2.24 | 0.443 | |
| 2zaz | GK1 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 3dpd | 41A | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.443 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.443 | |
| 3vew | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.443 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.443 | |
| 4dlj | 6RG | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 4ekk | ANP | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.443 | |
| 4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.443 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.443 | |
| 4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.443 | |
| 4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.443 | |
| 4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.443 | |
| 4otp | ADP | Serine/threonine-protein kinase RIO1 | 2.7.11.1 | 0.443 | |
| 4qmw | KS1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 1jvs | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.442 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2fto | CB3 | Thymidylate synthase | / | 0.442 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3cse | N22 | Uncharacterized protein | / | 0.442 | |
| 3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.442 | |
| 4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.442 | |
| 4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
| 4jx1 | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.442 | |
| 4l4c | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 1sj0 | E4D | Estrogen receptor | / | 0.441 | |
| 1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 2bkz | SBC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 2cah | NDP | Catalase | 1.11.1.6 | 0.441 | |
| 2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.441 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.441 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.441 | |
| 2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.441 | |
| 2w4k | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
| 2ww4 | ADP | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.441 | |
| 2x4z | X4Z | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.441 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.441 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.441 | |
| 3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.441 | |
| 3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.441 | |
| 3oib | FDA | Putative acyl-CoA dehydrogenase | / | 0.441 | |
| 3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
| 3w0r | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.441 | |
| 4h50 | NAP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.441 | |
| 4i8v | BHF | Cytochrome P450 1A1 | 1.14.14.1 | 0.441 | |
| 4in4 | 4ID | Kelch-like ECH-associated protein 1 | / | 0.441 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.441 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.441 | |
| 1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.440 | |
| 1p4f | DRG | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
| 2bhp | NAD | 1-pyrroline-5-carboxylate dehydrogenase | / | 0.440 | |
| 2w03 | ADN | AcsD | / | 0.440 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3bhy | 7CP | Death-associated protein kinase 3 | / | 0.440 | |
| 3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
| 3hz5 | Z64 | Heat shock protein HSP 90-alpha | / | 0.440 | |
| 3l9l | L9L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 3q92 | XNB | Ketohexokinase | / | 0.440 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.440 | |
| 3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.440 | |
| 4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 4app | N53 | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.440 | |
| 4bgq | 38R | Cyclin-dependent kinase-like 5 | 2.7.11.22 | 0.440 | |
| 4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.440 | |
| 4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.440 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.440 | |
| 5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
| 5c03 | AGS | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.440 | |
| 5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.440 |